@Haplo What are your thoughts on the detail and what will be included in the upcoming scoping study? Lately the ASX have been clamping down on Scoping Studies for using figures and costs. CLA’s SS for example.
- Forums
- ASX - By Stock
- KV Scoping study
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
84.5¢ |
Change
-0.010(1.17%) |
Mkt cap ! $1.612B |
Open | High | Low | Value | Volume |
85.0¢ | 86.5¢ | 83.5¢ | $5.151M | 6.083M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23487 | 84.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
85.0¢ | 286512 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1641167 | 0.019 |
3 | 712500 | 0.018 |
3 | 794117 | 0.017 |
1 | 200000 | 0.015 |
1 | 60000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1985261 | 1 |
0.021 | 1256198 | 4 |
0.022 | 1128862 | 5 |
0.023 | 1750000 | 3 |
0.024 | 480229 | 3 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online